Transplant-Related Hematologic Malignancy: Clinical Trials

4 trials for Transplant-Related Hematologic Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Not yet recruiting 1, Recruiting 1

Follow Transplant-Related Hematologic Malignancy: new trials by email Literature Review of Transplant-Related Hematologic Malignancy trials Research Report on Transplant-Related Hematologic Malignancy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Menin-Inhibitor Targeted Maintenance in AML
Revumenib, Placebo - Relapsed Adult AML, Stem Cell Transplant Complications
Phase 2Not yet recruitingCenter for International Blood and Marrow Transplant Research1462026-12-012026-06-22
GM-CSF With Post-Transplant Cyclophosphamide
Sargramostim, Control Arm - Transplant-Related Hematologic Malignancy
Phase 2RecruitingNorthside Hospital, Inc.382020-05-182026-10-14
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole
Conditioning treatment "Thiotepa-Treosulfan-Fludarabine", PBSC graft, GvHD prophylaxis - Transplant-Related Hematologic Malignancy, Leukemia, Acute
Phase 2CompletedCiceri Fabio102018-06-182022-07-19
Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant
Fludarabine, ARA-C, Treosulfan - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 2CompletedCiceri Fabio152009-02-102023-11-18

Narrower conditions

Leukemia, Myeloid, Acute (2)  ·  Myelodysplastic Syndromes (2)  ·  Graft vs Host Disease (1)  ·  Leukemia (1)  ·  Mycoses (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Bone Marrow Diseases (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid (2)  ·  Bacterial Infections and Mycoses (1)  ·  Immune System Diseases (1)  ·  Infections (1)

Interventions

Cytarabine (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  fludarabine (1)  ·  revumenib (1)  ·  sargramostim (1)  ·  treosulfan (1)

Sponsors

Ciceri Fabio (2)  ·  Center for International Blood and Marrow Transplant Research (1)  ·  Northside Hospital, Inc. (1)

Countries

Italy (2)  ·  United States (1)

Top investigators

Fabio Ciceri, MD (1)  ·  Melhem Solh, MD (1)  ·  Steven Devine, M.D (1)

NIH funding

2008 (1), 2017 (1)